Exploration of potential prognostic biomarkers in aflibercept plus FOLFIRI in Japanese patients with metastatic colorectal cancer. [electronic resource]
Producer: 20191112Description: 3565-3572 p. digitalISSN:- 1349-7006
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Asian People
- Biomarkers, Tumor -- blood
- Camptothecin -- analogs & derivatives
- Colonic Neoplasms -- blood
- Fluorouracil -- therapeutic use
- Humans
- Insulin-Like Growth Factor Binding Protein 1 -- blood
- Interleukin-8 -- blood
- Japan
- Kallikreins -- blood
- Leucovorin -- therapeutic use
- Placenta Growth Factor -- blood
- Prognosis
- Progression-Free Survival
- Prospective Studies
- Pulmonary Surfactant-Associated Protein D -- blood
- Receptor for Advanced Glycation End Products -- blood
- Receptors, Tumor Necrosis Factor, Type II -- blood
- Receptors, Vascular Endothelial Growth Factor -- therapeutic use
- Recombinant Fusion Proteins -- therapeutic use
- Rectal Neoplasms -- blood
- Regression Analysis
- Tenascin -- blood
- Tissue Inhibitor of Metalloproteinase-1 -- blood
- Vascular Endothelial Growth Factor Receptor-1 -- blood
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.